Drug-induced long QT syndrome: a continuing challenge in the field.
Glatter
Kathryn A
KA
Hamdan
Mohamed H
MH
Zhang
Qian
Q
Chiamvimonvat
Nipavan
N
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels / Q000037:antagonists & inhibitors / Q000235:genetics; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000235:genetics / Q000503:physiopathology*; D009154:Mutation; D026902:Potassium Channel Blockers / Q000009:adverse effects
D000889:Anti-Arrhythmia Agents; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels; D026902:Potassium Channel Blockers